These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33074124)

  • 21. [Function of alternative NF-κB activity in B-cell chronic lymphocytic leukemia cells].
    Xu J; Zhou P; Guo F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):40-5. PubMed ID: 24602731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
    Giopanou I; Lilis I; Papaleonidopoulos V; Marazioti A; Spella M; Vreka M; Papadaki H; Stathopoulos GT
    PLoS One; 2015; 10(7):e0132527. PubMed ID: 26147201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Atmospheric PM2.5 on Expression Levels of NF-κB Genes and Inflammatory Cytokines Regulated by NF-κB in Human Macrophage.
    Zhang Y; Wang S; Zhu J; Li C; Zhang T; Liu H; Xu Q; Ye X; Zhou L; Ye L
    Inflammation; 2018 Jun; 41(3):784-794. PubMed ID: 29396771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma.
    Eluard B; Nuan-Aliman S; Faumont N; Collares D; Bordereaux D; Montagne A; Martins I; Cagnard N; Caly M; Taoui O; Lordello L; Lehmann-Che J; Tesson B; Martinez-Climent JA; Copie-Bergman C; Haioun C; Tilly H; Bonsang B; Vincent-Salomon A; Jais JP; Jardin F; Leroy K; Maiuri MC; Kroemer G; Molina TJ; Feuillard J; Baud V
    Blood; 2022 Jan; 139(3):384-398. PubMed ID: 34232979
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Papoutsopoulou S; Tang J; Elramli AH; Williams JM; Gupta N; Ikuomola FI; Sheibani-Tezerji R; Alam MT; Hernández-Fernaud JR; Caamaño JH; Probert CS; Muller W; Duckworth CA; Pritchard DM
    Am J Physiol Gastrointest Liver Physiol; 2022 Oct; 323(4):G306-G317. PubMed ID: 35916405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RelB forms transcriptionally inactive complexes with RelA/p65.
    Marienfeld R; May MJ; Berberich I; Serfling E; Ghosh S; Neumann M
    J Biol Chem; 2003 May; 278(22):19852-60. PubMed ID: 12657634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic mutations in NF-κB pathway genes were associated with the protection from hepatitis C virus infection among Chinese Han population.
    Yue M; Tian T; Wang C; Fan H; Wu J; Wang J; Li J; Xia X; Zhang A; Yu R; Zhang Y; Huang P
    Sci Rep; 2019 Jul; 9(1):10830. PubMed ID: 31346215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
    Ok CY; Xu-Monette ZY; Li L; Manyam GC; Montes-Moreno S; Tzankov A; Visco C; Dybkær K; Routbort MJ; Zhang L; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Rao H; Møller MB; Winter JN; Piris MA; Wang SA; Medeiros LJ; Young KH
    Mod Pathol; 2015 Sep; 28(9):1202-13. PubMed ID: 26111978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?
    Fathi N; Mojtahedi H; Nasiri M; Abolhassani H; Yousefpour Marzbali M; Esmaeili M; Salami F; Biglari F; Rezaei N
    Expert Rev Clin Immunol; 2023 Mar; 19(3):329-339. PubMed ID: 36706462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Heterozygous Mutation in
    Aird A; Lagos M; Vargas-Hernández A; Posey JE; Coban-Akdemir Z; Jhangiani S; Mace EM; Reyes A; King A; Cavagnaro F; Forbes LR; Chinn IK; Lupski JR; Orange JS; Poli MC
    Front Pediatr; 2019; 7():303. PubMed ID: 31417880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa.
    Oswald F; Liptay S; Adler G; Schmid RM
    Mol Cell Biol; 1998 Apr; 18(4):2077-88. PubMed ID: 9528780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
    Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
    Front Immunol; 2019; 10():997. PubMed ID: 31134075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
    Yilmaz ZB; Weih DS; Sivakumar V; Weih F
    EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-expression of nuclear factor-κB family genes and inflammatory molecules is related to chronic obstructive pulmonary disease.
    Zhou L; Liu Y; Chen X; Wang S; Liu H; Zhang T; Zhang Y; Xu Q; Han X; Zhao Y; Song X; Ye L
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2131-2138. PubMed ID: 30034228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
    Allen C; Saigal K; Nottingham L; Arun P; Chen Z; Van Waes C
    Clin Cancer Res; 2008 Jul; 14(13):4175-85. PubMed ID: 18593997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-κB2/p100 deficiency impairs immune responses to T-cell-independent type 2 antigens.
    Krljanac B; Weih D; Jacobsen ID; Hu D; Koliesnik I; Reppe K; Witzenrath M; Weih F
    Eur J Immunol; 2014 Mar; 44(3):662-72. PubMed ID: 24242887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
    Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
    Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
    Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study.
    Lessard L; Bégin LR; Gleave ME; Mes-Masson AM; Saad F
    Br J Cancer; 2005 Oct; 93(9):1019-23. PubMed ID: 16205698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.